SpeziMed GmbH operates a specialist trade in medical devices for people with diabetes and provides medical-technical consulting and service through specially trained staff. The owner-managed, independent and product-neutral company operates nationwide as a service provider and contractual partner of statutory health insurers and maintains regional presence via a field sales force and currently 23 specialized diabetes shops. For corporate management, revenue- and profit-related KPIs from cost-center accounting are used, and no product development was carried out in the 2024 financial year. In 2024 the company employed on average 73 employees (29 full-time, 44 part-time) and generated an annual surplus of TEUR 839.0.
Betrieb eines Spezialhandels für Medizinprodukte für Endkunden unter Ausschluss von solchen Gegenständen, für deren Handel eine staatliche Genehmigung erforderlich ist.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Dresden Local Court, HRB 26733 (as of 2 November 2026)
| Name | Type | City |
|---|---|---|
| Matthias Leonhardt | Geschäftsführer(in) | Pirna OT Graupa |
Source: German Commercial Register (Handelsregister) Dresden Local Court, HRB 26733 (as of 2 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 20.12.2024 | Registered Seat Change | Dresden |
| 20.12.2024 | Business Address Change | Franklinstr. 22, 01069 Dresden |
| 20.12.2024 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 25.06.2008 | Share Capital Set | — | 60.000 € |
Source: German Commercial Register (Handelsregister) Dresden Local Court, HRB 26733 (as of 2 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | Rohergebnis€6.7M2 | €841,858 | €4,556,962 | — |
| 2023 | Rohergebnis€6.5M2 | €672,246 | €4,128,403 | — |
| 2022 | Rohergebnis€5.5M2 | €152,703 | €4,014,839 | — |
| 2021 | Rohergebnis€5.4M2 | €429,072 | €3,726,319 | — |
| 2020 | Rohergebnis€6.4M2 | €805,093 | €3,560,284 | — |
| 2019 | Rohergebnis€4.8M2 | €612,901 | €3,086,670 | — |
| 2018 | Rohergebnis€3.8M2 | €265,085 | €2,390,796 | — |
| 2017 | Rohergebnis€3.3M2 | €126,966 | €2,382,980 | — |
| 2016 | Rohergebnis€3.2M2 | €282,855 | €2,340,262 | — |
| 2015 | small company1 | €101,766 | €2,292,188 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Dresden Local Court, HRB 26733 (as of 2 November 2026)
Sanitätshaus Fuchs & Möller GmbH
Mannheim · Einzelhandel mit sonstigen medizinischen und orthopädischen Artikeln
CSZ Corona Schnelltest Zentrum UG (haftungsbeschränkt)
Bonn · Einzelhandel mit sonstigen medizinischen und orthopädischen Artikeln
air-be-c Medizintechnik GmbH
Gera · Einzelhandel mit sonstigen medizinischen und orthopädischen Artikeln
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €3,647,758 | 95.3% |
| Depreciation | €117,464 | 3.1% |
| Interest & Similar | €61,450 | 1.6% |
